Conférences - Maladies Infectieuses

SMi Group

As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless. This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.

Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.superbugssuperdrugs.com/

Tél.: [02078276000];     Email.: events@smi-online.co.uk

Resistance; superbugs; superdrugs; mrsa; infectious diseases; investment; smart materials, infection, drug discovery, antibacterial, antimicrobial, anti-infective, multidrug resistance, MDR, diagnostics, immunization, inhibitors, antibiotic, resistance, antibiotic resistance, vaccine, bacterial, infections, drive a-b, genome sequencing, multi-resistant gram-negative, BARDA, Microbiota, EBOLA, bacteria, biotech, biomedical, pem, disease, amr, ppp, health, containment, microbiology, hepatitis, hcv, clinical, lab, gram positive, gram negative, fungi, fungal, population, contamination, viral, virus, amr, zika, fda, pathogen

Pharmacologie et développement des médicaments,    Immunologie et Allergie

Harvard Medical School

This comprehensive Harvard Medical School CME program—one of the highest-rated HMS CME courses-- ensures attendees are current with state-of-the-art approaches to prevention, detection, diagnosis and treatment of infectious diseases. Updates, best practices and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results driven: Strategies for optimal decision-making in the prevention, diagnosis and treatment of infectious diseases -- Newer antimicrobials and treatment strategies for highly resistant bacterial infections -- Prevention and treatment of infection in immunocompromised hosts -- State-of-the-art approaches to common infections -- Clinical approaches to complex, rare, "don't-miss" infections -- New, evolving, and emerging infectious diseases -- Update on antifungal diagnostics and therapy -- Optimal management of Staph aureus infections -- Infections in persons with substance use disorders -- What’s new in HIV management and prevention -- Musculoskeletal infectious diseases -- ID for hospital medicine specialists -- Workshop on resistant and difficult-to-treat infections -- Workshop on antimicrobial stewardship -- As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work. Please visit the course website at https://id.hmscme.com for a complete schedule and a comprehensive list of course highlights.

Tél.: [617-384-8600];     Email.: CEPrograms@hms.harvard.edu

Harvard, infections, comprehensive, CME, antimicrobials, immunocompromised hosts, antifungals, HIV, resistant infections, antimicrobial stewardship, substance use disorders, emerging infectious diseases, zoonoses, tick-borne, ENT, Vaccines, Clostridium difficile, Zika, EEE, sexually transmitted infections, Hepatitis, MRSA, OPAT, detection, diagnosis, treatment

Tél.: [+49 89 890677 0];     Email.: info@cocs.de

Greetings from Vaccines Congress 2020!! We take great pleasure in inviting Participants to the upcoming 3rd European Congress on Vaccines and Immunology during July 15-16, 2020 at London, UK on the theme “Emphasizing the Challenges and Advancements in Vaccines & Immunization”

Tél.: [2033182512];     Email.: alexjones.vaccines@gmail.com

Vaccines, Immunology, Pathology, Microbiology, Vaccination, Immunization, Pathogenesis, Immunity, Infectious Diseases, Allergy, Asthma, Emergency Medicine, Oncology, Toxicology, Virology, Internal Medicine, HIV, AIDS, Viruses, Microbial, Parasitology, Epidemiology, HPV, Veterinary Vaccines

Formation médicale continue (FMC),    Immunologie et Allergie

Organising Secretariat - Ashfield Healthcare Communications

The HIV Glasgow programme is of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there has been steady progress in HIV drug treatment, significant challenges still remain, including persistence of elevated risk of non-AIDS morbidity, with potential for HIV and/or antiretroviral therapy (ART) as causes, paediatric and adolescent care, models of care for the ageing population, and treatment issues throughout less well-resourced parts of Europe and the rest of the world. The Congress is also moving into areas beyond treatment, such as prevention, with time in the programme focussed on pre-exposure prophylaxis (PrEP) and issues across Europe and beyond. The important role of people living with HIV in treatment decisions and self-management continues to feature, and we look forward to a number of perspectives in the programme from the community.

Email.: hivglasgow@ashfieldhealthcare.com

American Medical Seminars

Following this course, the participant should be able to recognize the epidemiology, demographics and common clinical presentations for the diseases and disorders discussed; construct an appropriate history, physical exam and laboratory evaluation to develop cost-effective and accurate diagnosis; manage as well as employ appropriate follow-up and/or specialty referral for the diseases and disorders presented. This activity is expected to result in improved competence in making appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes.The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include Emergency Medicine, this course was designed to cover Infectious Diseases and Emergency related diseases/disorders commonly seen by today’s PCP.

American Medical Seminars;     Tél.: [9413881776];     Email.: mail@ams4cme.com

CME Conference, Medical Conference, CME 2020, CME South Carolina, CME Live, Medical Conferences South Carolina, Live CME Seminars, Travel CME, Family Medicine CME, Internal Medicine CME, Emergency Medicine CME, Primary Care CME, CME Courses, South Carolina, CME Myrtle Beach

Médecine d'urgence & réanimation,    Médecine (en général)

American Medical Seminars

Following this course, the participant should be able to appraise the epidemiology and classify commonly presenting infectious diseases; differentiate among the various serious infections requiring immediate therapy; apply appropriate use of laboratory studies and determine when to refer to a specialist. This activity is expected to result in improved competence in making an appropriate diagnosis and providing effective treatment and referral or follow-up care with the overall goal of improving patient outcomes. The emphasis will be on aligning physician behavior with current guidelines and evidence-based medicine, as indicated within each topic’s specific objectives, with a focus on diagnosis, treatment and when to refer. Since Infectious Diseases is a specialty field of medicine that affects all areas of Primary Care to include: FM, IM, EM and Pediatrics, this course was designed to cover the spectrum of Infectious Diseases essential to all practitioners at the level of a practicing physician.

American Medical Seminars;     Tél.: [9413881776];     Email.: mail@ams4cme.com

CME Conference, Medical Conference, CME 2020, CME Georgia, CME Live, Medical Conferences Georgia, Live CME Seminars, Travel CME, Family Medicine CME, Internal Medicine CME, Emergency Medicine CME, Primary Care CME, CME Courses, Georgia, CME Savannah

Pédiatrie,    Médecine d'urgence & réanimation